Andrew Levin

Andrew Levin is a seasoned professional in the healthcare and investment sectors, currently serving as Partner and Managing Director at RA Capital Management, LLC since 2015, and as President and Founder of Carnot Pharma since 2016. Prior experience includes roles as Vice President at H.I.G. Capital from 2012 to 2015 and Director at the Clinton Health Access Initiative from 2010 to 2012. Andrew Levin holds an MD from Harvard Medical School (2005-2007), a PhD in Biomedical Engineering from the Massachusetts Institute of Technology (2000-2005), and a BSE in Mechanical Engineering from Princeton University (1995-1999).